nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study
|
Delabre, Rosemary Markovic |
|
2015 |
33 |
49 |
p. 7015-7021 7 p. |
artikel |
2 |
Building a new communication paradigm: Can we influence influenza perception?
|
Jit, Mark |
|
2015 |
33 |
49 |
p. 7044-7046 3 p. |
artikel |
3 |
Conclusions: From peer to peer communication to communicating with policy makers and the general public
|
|
|
2015 |
33 |
49 |
p. 7047- 1 p. |
artikel |
4 |
Editorial Board/Aims and Scope
|
|
|
2015 |
33 |
49 |
p. IFC- 1 p. |
artikel |
5 |
Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses
|
Kiseleva, Irina |
|
2015 |
33 |
49 |
p. 7008-7014 7 p. |
artikel |
6 |
Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus
|
Wiersma, Lidewij C.M. |
|
2015 |
33 |
49 |
p. 6977-6982 6 p. |
artikel |
7 |
How should influenza be treated? Focus on antivirals
|
van Essen, G(errit) A. |
|
2015 |
33 |
49 |
p. 7033-7036 4 p. |
artikel |
8 |
Influenza vaccines really work? Keeping apart the true from the false
|
Nguyen-Van-Tam, Jonathan |
|
2015 |
33 |
49 |
p. 7029-7032 4 p. |
artikel |
9 |
Influenza vaccines: Where do we stand? Where do we go?
|
Rimmelzwaan, Guus |
|
2015 |
33 |
49 |
p. 7026-7028 3 p. |
artikel |
10 |
Pathogenicity evaluation of neuraminidase-negative H5 and H7 viruses in day-old chicks and adult chicken
|
Hoffmann, Donata |
|
2015 |
33 |
49 |
p. 6997-7001 5 p. |
artikel |
11 |
Proceedings Fifth ESWI Influenza Conference
|
Osterhaus, A.D.M.E. |
|
2015 |
33 |
49 |
p. 6947-6948 2 p. |
artikel |
12 |
Putting flu on the agenda
|
Russell, Colin |
|
2015 |
33 |
49 |
p. 7041-7043 3 p. |
artikel |
13 |
Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment
|
Reperant, Leslie A. |
|
2015 |
33 |
49 |
p. 6955-6966 12 p. |
artikel |
14 |
Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000–2012
|
Van Kerkhove, Maria D |
|
2015 |
33 |
49 |
p. 6970-6976 7 p. |
artikel |
15 |
S-acylation of influenza virus proteins: Are enzymes for fatty acid attachment promising drug targets?
|
Veit, Michael |
|
2015 |
33 |
49 |
p. 7002-7007 6 p. |
artikel |
16 |
Sex differences in H7N9 influenza A virus pathogenesis
|
Hoffmann, Julia |
|
2015 |
33 |
49 |
p. 6949-6954 6 p. |
artikel |
17 |
Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8+-mediated cross protection against influenza
|
Baranowska, Marta |
|
2015 |
33 |
49 |
p. 6988-6996 9 p. |
artikel |
18 |
The ESPID/ESWI Joint Symposium—A strong vote for universal influenza vaccination in children in Europe
|
Kobbe, Robin |
|
2015 |
33 |
49 |
p. 6967-6969 3 p. |
artikel |
19 |
Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation
|
Wiersma, Lidewij C.M. |
|
2015 |
33 |
49 |
p. 6983-6987 5 p. |
artikel |
20 |
Why should influenza be a public health priority?
|
Osterhaus, Ab |
|
2015 |
33 |
49 |
p. 7022-7025 4 p. |
artikel |
21 |
Will there ever be a new influenza pandemic and are we prepared?
|
Rudenko, Larisa |
|
2015 |
33 |
49 |
p. 7037-7040 4 p. |
artikel |